Rate Video

EHA 2018 | Making CAR T-cells happen in Europe

John Gribben • 16 Jun 2018

Chronic Lymphocytic Leukemia General Leukemia Lymphoma CAR-T

John Gribben, of Barts Cancer Institute, London, UK, discusses making CAR T-cells happen in Europe. This video was recorded at the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden.

iwNHL 2015 roundtable: Day 2 highlights – ibrutinib for diffuse large B-cell lymphoma

John Gribben et al. • 3 Oct 2015

Where are we with precision medicine for CLL?

John Gribben • 16 Sep 2016

Phase II trial of venetoclax monotherapy for relapsed/refractory CLL with 17p deletion

John Gribben et al. • 3 Dec 2015

Patient risk stratification in CLL and selection of treatment approaches

John Gribben • 9 Jun 2022

Related Videos

Current standard of care in BPDCN

Uwe Platzbecker • 21 Jun 2022

Dose-adjusted EPOCH plus inotuzumab ozogamicin for B-ALL

Ryan Cassaday • 20 Jun 2022

Updated PFS results of the GAIA/CLL13 trial

Barbara Eichhorst • 20 Jun 2022

The benefits of next-generation BTK inhibitors in CLL

Barbara Eichhorst • 20 Jun 2022